Adenoid Cystic Carcinoma: Participation of Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR) in Tumor Invasion

被引:1
|
作者
Shirasuna, Kanemitsu [1 ]
机构
[1] Kyushu Univ, Grad Sch Dent Sci, Dept Oral & Maxillofacial Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan
关键词
adenoid cystic carcinoma; recurrence; invasion and metastasis; urokinase-type plasminogen activator (uPA); uPA receptor; plasminogen activator inhibitor type 1; matrix degradation; integrins; cell migration; focal adhesion;
D O I
10.1016/S1348-8643(05)80009-6
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Adenoid cystic carcinoma (AdCC) is one of the most common malignant tumors of the salivary glands and has unique clinical features and behavior. AdCC grows slowly, but spreads relentlessly into adjacent tissues, with a proclivity for invading nerve and endothelial sheaths. Moreover, the frequency of recurrence and distant metastasis of AdCC is very high. In vivo and in vitro, AdCC produces a large amount of extracellular matrix (ECM), including basement membrane (BM) components, elastin, and mucopolysaccharides. The accumulation of ECM components in intercellular spaces results in the formation of a pseudocyst, which is the characteristic architecture of AdCC. AdCC cells degrade considerable amounts of mesenchymal-elaborated ECM through the urokinase- type plasminogen activator (uPA) - plasmin system. By contrast, tumor- produced ECM is resistant to degradation, because it contains plasminogen activator inhibitor type 1 (PAI-1). The migration response of AdCC cell lines to ECM, especially type I and type IV collagens, is much stronger than that of oral squamous cell carcinoma (SCC cell lines, while both cell types generally show similar patterns of integrin subunit expression. The AdCC cell response to collagens is largely and exclusively inhibited by anti-alpha(2) integrin antibody. Surface uPA receptor (uPAR) expression by AdCC cell lines is greater than that by SCC cell lines and increases in response to collagen stimulation. This is accompanied by the assembly of numerous focal adhesions, consisting of the adapter proteins uPAR, alpha(2) integrin, vinculin, and paxillin. A role for uPAR in cell migration and assembly of adaptor proteins was also demonstrated by transfecting AdCC cells with an antisense uPAR RNA, which strongly reduced both responses. Therefore, the proclivity of AdCC cells to migrate to type I and IV collagens might be due to the overexpression of uPAR, which also plays a key role in focal adhesion assembly. In conclusion, the invasiveness of AdCC cells might be regulated by the interaction of uPA-uPAR with integrin.
引用
收藏
页码:69 / 79
页数:11
相关论文
共 50 条
  • [1] Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides
    Burgle, M
    Koppitz, M
    Riemer, C
    Kessler, H
    Konig, B
    Weidle, UH
    Kellermann, J
    Lottspeich, F
    Graeff, H
    Schmitt, M
    Goretzki, L
    Reuning, U
    Wilhelm, O
    Magdolen, V
    BIOLOGICAL CHEMISTRY, 1997, 378 (3-4) : 231 - 237
  • [2] Urokinase-type plasminogen activator (uPA) and its receptor (uPAR):: Development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivo
    Reuning, U
    Sperl, S
    Kopitz, C
    Kessler, H
    Krüger, A
    Schmitt, M
    Magdolen, V
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (19) : 1529 - 1543
  • [3] Urokinase-type plasminogen activator receptor expression of the skull in adenoid cystic carcinoma base
    Doerr, TD
    Marentette, LJ
    Flint, A
    Elner, V
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (02) : 215 - 218
  • [4] Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration
    Pliyev, Boris K.
    Antonova, Olga A.
    Menshikov, Mikhail
    MOLECULAR IMMUNOLOGY, 2011, 48 (9-10) : 1168 - 1177
  • [5] Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
    Mahmood, Niaz
    Mihalcioiu, Catalin
    Rabbani, Shafaat A.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [6] Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System
    Merino, Paola
    Diaz, Ariel
    Jeanneret, Valerie
    Wu, Fang
    Torre, Enrique
    Cheng, Lihong
    Yepes, Manuel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (07) : 2741 - 2753
  • [7] Calcitonin inhibits invasion of breast cancer cells: Involvement of urokinase-type plasminogen activator (uPA) and uPA receptor
    Han, B
    Nakamura, M
    Zhou, GY
    Ishii, A
    Nakamura, A
    Bai, YH
    Mori, I
    Kakudo, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (04) : 807 - 814
  • [8] Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
    Bing-Tao Zhai
    Huan Tian
    Jing Sun
    Jun-Bo Zou
    Xiao-Fei Zhang
    Jiang-Xue Cheng
    Ya-Jun Shi
    Yu Fan
    Dong-Yan Guo
    Journal of Translational Medicine, 20
  • [9] EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS RECEPTOR (UPAR) IN HUMAN OVARIAN-CANCER CELLS AND IN-VITRO INVASION CAPACITY
    WILL, C
    WILHELM, O
    HOHL, S
    MOBUS, V
    WEIDLE, U
    KREIENBERG, R
    JANICKE, F
    SCHMITT, M
    GRAEFF, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 5 (04) : 753 - 761
  • [10] Structural aspects of urokinase-type plasminogen activator receptor (uPAR) function
    Ploug, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 : 25 - 25